Comparison of the Influence of Cyclosporine and Tacrolimus on the Pharmacokinetics of Prednisolone in Adult Male Kidney Transplant Recipients

Overview

Journal Clin Drug Investig

Date 2014 Jan 4

PMID 24385281

Citations 5

Authors

Troels K Bergmann

Nicole M Isbel

Katherine A Barraclough

Scott B Campbell

Brett C McWhinney

Christine E Staatz

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Cyclosporine has been observed to precipitate cushingoid features in kidney transplant recipients already on prednisolone. Some pharmacokinetic studies have demonstrated increased prednisolone exposure in patients on cyclosporine therapy compared with azathioprine, whereas other studies have found no difference. The objective of this study was to determine whether cyclosporine impacts on prednisolone exposure as compared with tacrolimus.

Methods: Adult male kidney transplant recipients treated with prednisolone and either cyclosporine or tacrolimus were recruited for pharmacokinetic blood sampling at the outpatient clinic at the Princess Alexandra Hospital, Brisbane, Australia. Prednisolone plasma concentrations were determined using ultra-high-performance liquid chromatography. Dose-adjusted area under the plasma concentration-time curve (AUC) of free and total prednisolone was estimated using a previously developed limited sampling strategy and non-compartmental analysis.

Results: A total of 55 patients were eligible for analysis; 38 % received cyclosporine and 62 % received tacrolimus co-therapy. No significant difference in mean dose-adjusted total prednisolone AUC from 0 to 6 h post-dose or mean dose-adjusted free prednisolone AUC from 0 to 12 h was observed between the cyclosporine and tacrolimus groups (449 versus 428 nmol·h/L/mg, p = 0.43, and 32 versus 30 nmol·h/L/mg, p = 0.51, respectively).

Conclusion: Cyclosporine does not change the dose-adjusted exposure of prednisolone compared with tacrolimus. Adult kidney transplant recipients can therefore continue on their usual prednisolone dose when changing therapy between cyclosporine and tacrolimus.

Citing Articles

Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Based Immunosuppression.

Yousif E, Abdelwahab A Cureus. 2022; 14(2):e22285.

PMID: 35350492 PMC: 8932594. DOI: 10.7759/cureus.22285.

Current status of glucocorticoid usage in solid organ transplantation.

Dashti-Khavidaki S, Saidi R, Lu H World J Transplant. 2021; 11(11):443-465.

PMID: 34868896 PMC: 8603633. DOI: 10.5500/wjt.v11.i11.443.

The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells.

Sakata N, Yoshimatsu G, Kodama S Int J Mol Sci. 2018; 19(5).

PMID: 29735923 PMC: 5983746. DOI: 10.3390/ijms19051391.

Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients.

Bergmann T, Isbel N, Ostini R, Barraclough K, Campbell S, McWhinney B Clin Drug Investig. 2015; 35(11):743-50.

PMID: 26403249 DOI: 10.1007/s40261-015-0334-2.

Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis.

Abd Rahman A, Tett S, Abdul Gafor H, McWhinney B, Staatz C Br J Clin Pharmacol. 2015; 80(5):1064-75.

PMID: 25959850 PMC: 4631179. DOI: 10.1111/bcp.12678.

References

Robieux I, Dorian P, Klein J, Chung D, Ogilvie R, Koren G . The effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokinetics. J Clin Pharmacol. 1992; 32(4):338-43. DOI: 10.1002/j.1552-4604.1992.tb03845.x. View

McMillan M . Clinical pharmacokinetics of cyclosporin. Pharmacol Ther. 1989; 42(1):135-56. DOI: 10.1016/0163-7258(89)90025-9. View

Frey F, Schnetzer A, Horber F, Frey B . Evidence that cyclosporine does not affect the metabolism of prednisolone after renal transplantation. Transplantation. 1987; 43(4):494-8. DOI: 10.1097/00007890-198704000-00007. View

Langhoff E, Madsen S, Flachs H, Olgaard K, LADEFOGED J, Hvidberg E . Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients. Transplantation. 1985; 39(1):107-9. View

Ost L . Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients. Transplantation. 1987; 44(4):533-5. View

Magee M, Blum R, Lates C, Jusko W . Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol. 2001; 41(11):1180-94. PMC: 4207281. DOI: 10.1177/00912700122012733. View

Ost L . Effects of cyclosporin on prednisolone metabolism. Lancet. 1984; 1(8374):451. DOI: 10.1016/s0140-6736(84)91778-1. View

Rebello S, Compain S, Feng A, Hariry S, Dieterich H, Jarugula V . Effect of cyclosporine on the pharmacokinetics of aliskiren in healthy subjects. J Clin Pharmacol. 2011; 51(11):1549-60. DOI: 10.1177/0091270010385934. View

Saitoh H, Saikachi Y, Kobayashi M, Yamaguchi M, Oda M, Yuhki Y . Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine. Eur J Pharm Sci. 2006; 28(1-2):34-42. DOI: 10.1016/j.ejps.2005.12.006. View

10.

Bergmann T, Barraclough K, Lee K, Staatz C . Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation. Clin Pharmacokinet. 2012; 51(11):711-41. DOI: 10.1007/s40262-012-0007-8. View

11.

Kawai R, Mathew D, Tanaka C, Rowland M . Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human. J Pharmacol Exp Ther. 1998; 287(2):457-68. View

12.

Shitara Y, Itoh T, Sato H, Li A, Sugiyama Y . Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp Ther. 2003; 304(2):610-6. DOI: 10.1124/jpet.102.041921. View

13.

Vogt M, Derendorf H, Kramer J, Junginger H, Midha K, Shah V . Biowaiver monographs for immediate release solid oral dosage forms: prednisolone. J Pharm Sci. 2006; 96(1):27-37. DOI: 10.1002/jps.20768. View

14.

de Jonge H, de Loor H, Verbeke K, Vanrenterghem Y, Kuypers D . In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients. Clin Pharmacol Ther. 2011; 90(3):414-22. DOI: 10.1038/clpt.2011.130. View

15.

Boekenoogen S, Szefler S, Jusko W . Prednisolone disposition and protein binding in oral contraceptive users. J Clin Endocrinol Metab. 1983; 56(4):702-9. DOI: 10.1210/jcem-56-4-702. View

16.

Dorian P, Cardella C, Strauss M, David T, East S, Ogilvie R . Cyclosporine nephrotoxicity and cyclosporine--digoxin interaction prior to heart transplantation. Transplant Proc. 1987; 19(1 Pt 2):1825-7. View

17.

Lensmeyer G, Wiebe D, CARLSON I, Subramanian R . Concentrations of cyclosporin A and its metabolites in human tissues postmortem. J Anal Toxicol. 1991; 15(3):110-5. DOI: 10.1093/jat/15.3.110. View

18.

McWhinney B, Briscoe S, Ungerer J, Pretorius C . Measurement of cortisol, cortisone, prednisolone, dexamethasone and 11-deoxycortisol with ultra high performance liquid chromatography-tandem mass spectrometry: Application for plasma, plasma ultrafiltrate, urine and saliva in a routine laboratory. J Chromatogr B Analyt Technol Biomed Life Sci. 2010; 878(28):2863-9. DOI: 10.1016/j.jchromb.2010.08.044. View

19.

Bergman A, Burke J, Larson P, Johnson-Levonas A, Reyderman L, Statkevich P . Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients. J Clin Pharmacol. 2006; 46(3):328-36. DOI: 10.1177/0091270005284852. View

20.

Barraclough K, Isbel N, McWhinney B, Ungerer J, Medley G, Johnson D . Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. Eur J Clin Pharmacol. 2011; 67(12):1243-52. DOI: 10.1007/s00228-011-1071-y. View